Mao Ding
Impact in
- Geriatrics and Gerontology top 10%
- Sirtuins and Resveratrol in Medicine
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- RNA regulation and disease 2
-
- Alzheimer's disease research and treatments 6
- Co-authors
- Bangmin Han (4 shared papers)Chenyi Jiang (3 shared papers)Shujie Xia (3 shared papers)Yaqin Zhang (1 shared paper)Shanchen Pang (1 shared paper)Xun Wang (1 shared paper)Xian-Jin Xie (1 shared paper)Jing Zhao (1 shared paper)
- Journals
- Journal of Experimental & Clinical Cancer Research (3 papers)Neuroreport (2 papers)Journal of Alzheimer s Disease (2 papers)BMC Nephrology (2 papers)Asian Journal of Andrology (1 paper)
- Partner nations
- ChinaUnited StatesFinland
In The Last Decade
Mao Ding
24 papers receiving 419 citations
Peers
Comparison fields: 5 of 86
- Geriatrics and Gerontology 31
- Cancer Research 111
- Neurology 32
- Molecular Biology 191
- Pulmonary and Respiratory Medicine 77
Countries citing papers authored by Mao Ding
This map shows the geographic impact of Mao Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mao Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mao Ding more than expected).
Fields of papers citing papers by Mao Ding
This network shows the impact of papers produced by Mao Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mao Ding. The network helps show where Mao Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Mao Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 69 | |
| 2 | 2020 | 62 | |
| 3 | 2020 | 60 | |
| 4 | 2019 | 53 | |
| 5 | 2018 | 28 | |
| 6 | 2018 | 27 | |
| 7 | 2021 | 27 | |
| 8 | 2023 | 15 | |
| 9 | 2019 | 14 | |
| 10 | 2022 | 13 | |
| 11 | 2018 | 10 | |
| 12 | 2022 | 9 | |
| 13 | 2021 | 9 | |
| 14 | 2024 | 6 | |
| 15 | 2025 | 5 | |
| 16 | 2021 | 4 | |
| 17 | 2023 | 4 | |
| 18 | 2024 | 2 | |
| 19 | 2024 | 2 | |
| 20 | 2023 | 2 |
About Mao Ding
Mao Ding is a scholar working on Molecular Biology, Physiology, Pulmonary and Respiratory Medicine, Cancer Research and Surgery, having authored 25 papers that have together received 425 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (6 papers), Prostate Cancer Treatment and Research (3 papers), Trace Elements in Health (3 papers), Tryptophan and brain disorders (2 papers), Prostate Cancer Diagnosis and Treatment (2 papers), RNA regulation and disease (2 papers), Cholinesterase and Neurodegenerative Diseases (2 papers) and Topology Optimization in Engineering (2 papers). The work is most often cited by research in Geriatrics and Gerontology (31 citations), Cancer Research (111 citations), Neurology (32 citations), Molecular Biology (191 citations) and Pulmonary and Respiratory Medicine (77 citations). Mao Ding has collaborated with scholars based in China, United States and Finland. Frequent co-authors include Bangmin Han, Chenyi Jiang, Shujie Xia, Yaqin Zhang, Shanchen Pang, Xun Wang, Xian-Jin Xie, Jing Zhao, Zhaohong Xie and Yu Zhang. Their work appears in journals such as Journal of Experimental & Clinical Cancer Research, Neuroreport, Journal of Alzheimer s Disease, BMC Nephrology and Asian Journal of Andrology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.